RNS Number : 3995F

Societe Generale SA

16 November 2020

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	US$0.000304635 ordinary shares
Date of dealing	13/11/2020

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	429,396	0.33	1,611	0.00
(2) Derivatives (other than options)	1,490	0.00	12,296	0.01
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	*1,552,877	*1.20	13,907	0.01

* Include the holding of 1,121,991 shares on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit USD (Note 5)
Purchase	106	203.8
Purchase	41	203.8
Purchase	1	207.4
Purchase	16	207.4
Purchase	100	206.84
Purchase	28	206.94
Purchase	721	206.81
Purchase	2,915	206.81
Sale	2	203.8
Sale	6	207.31
Sale	28	207.31
Sale	53	204.71
Sale	47	204.71
Sale	66	207.31
Sale	100	205.45
Sale	13	206.62
Sale	87	206.62
Sale	27	207.4
Sale	100	205.19
Sale	13	207.4
Sale	60	207.4
Sale	69	205.01
Sale	17	207.29
Sale	23	207.29
Sale	60	207.29
Sale	83	205.28
Sale	60	207.36
Sale	20	207.36
Sale	20	207.36
Sale	31	205.01
Sale	6	206.66
Sale	5	206.66
Sale	9	206.66
Sale	51	206.66
Sale	19	206.66
Sale	10	206.66
Sale	4	206.47
Sale	42	206.47
Sale	54	206.47
Sale	76	206.94
Sale	24	206.94
Sale	2	206.74
Sale	20	206.74
Sale	47	206.74
Sale	31	206.74
Sale	100	206.96
Sale	4	207.29
Sale	100	205.97
Sale	100	207.3
Sale	100	206.81
Sale	100	206.81
Sale	3	205.02
Sale	100	206.66
Sale	84	206.76
Sale	55	207.43
Sale	16	206.76
Sale	1	207.25
Sale	99	207.25
Total Purchases	3,928
Total Sales	2,247

(b)      Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit USD (Note 5)
CFD	Increased short	2,915	206.81
Euro Medium Term Note	Increased Long	3	205.02

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option Number of securities Exercise price per unit (Note 5)

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	16/11/2020
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEFIFEDLILRLII